Longaeva Partners’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.31M Buy
+318,181
New +$3.6M 0.07% 213
2026
Q1
– Sell
-98,040
Closed -$513K – 227
2025
Q4
$513K Buy
+98,040
New +$403K 0.04% 112

Other funds holding IMMX

Longaeva Partners's IMMX Position: Q3 2026 in Review

Longaeva Partners opened a new position in Immix Biopharma (IMMX) in Q3 2026: 318,181 shares worth $3.31M. The stake represents 0.07% of the portfolio and ranks #213 among its holdings. This is a return to the name: Longaeva Partners previously reported a position in IMMX as recently as Q4 2025.

Longaeva Partners first reported a position in IMMX in Q4 2025 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Longaeva Partners held 318,181 shares of Immix Biopharma worth $3.31M as of Q3 2026.
  • Immix Biopharma was a new Longaeva Partners position in Q3 2026.
  • Immix Biopharma made up 0.07% of Longaeva Partners's portfolio in Q3 2026, its #213 holding.
  • Longaeva Partners first reported a position in Immix Biopharma in Q4 2025 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.